Atlas Trials

Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

Clinical trial NCT00177307 · COMPLETED

Trial details

NCT number
NCT00177307
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2005-01-01
Primary completion
2012-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.